Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 20;62(13):e202218907.
doi: 10.1002/anie.202218907. Epub 2023 Feb 20.

A Bidentate Ligand Featuring Ditopic Lewis Acids in the Second Sphere for Selective Substrate Capture and Activation

Daniel M Beagan  1 , John J Kiernicki  1   2 , Matthias Zeller  3 , Nathaniel K Szymczak  1
Affiliations

A Bidentate Ligand Featuring Ditopic Lewis Acids in the Second Sphere for Selective Substrate Capture and Activation

Daniel M Beagan et al. Angew Chem Int Ed Engl. .

Abstract

We present a ligand platform featuring appended ditopic Lewis acids to facilitate capture/activation of diatomic substrates. We show that incorporation of two 9-borabicyclo[3.3.1]nonane (9-BBN) units on a single carbon tethered to a pyridine pyrazole scaffold maintains a set of unquenched nitrogen donors available to coordinate FeII , ZnII , and NiII . Using hydride ion affinity and competition experiments, we establish an additive effect for ditopic secondary sphere boranes, compared to the monotopic analogue. These effects are exploited to achieve high selectivity for binding NO2 - in the presence of competitive anions such as F- and NO3 - . Finally, we demonstrate hydrazine capture within the second-sphere of metal complexes, followed by unique activation pathways to generate hydrazido and diazene ligands on Zn and Fe, respectively.

Keywords: Chemoselective Anion Binding; Ditopic Boranes; Hydrazine Functionalization; Lewis Acids; Secondary Coordination Sphere.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Selected examples of known ditopic boranes,[11, 12b, 14, 15e] and design strategy outlining the ditopic ligand used in this work from prior work using a bidentate ligand with single second-sphere Lewis acid,[9a-c] and a tridentate ligand with two Lewis acids,[4, 9d, 9e]
Figure 2.
Figure 2.
a) Synthesis of (ene)BBNtBuFeBr2 via post-metalation hydroboration and synthesis of 1 and 2–4 via pre-metalation hydroboration b) molecular structures (50% probability ellipsoids) of 1, (propargyl)BBNtBuFeBr2, (ene)BBNtBuFeBr2, and 2. H-atoms excluding (ene) and (propargyl) groups are omitted, and the 9-BBN substituents are displayed in wireframe for improved clarity.
Figure 3.
Figure 3.
a) Anion capture mediated by 1 yielding ditopic boron containing heterocyles 1-OAc, 1-NO2, and 1-H and their respective molecular structures b) Comparison vs. free ligand (yellow) of distortion for ditopic borane unit with each heterocycle (blue) c) Comparative thermodynamics for nitrite and hydride capture for 1 and 1-mono and d) Comparative pKa values for hydrazine N-H protons. R represents the remainder of free ligand. Thermal ellipsoids displayed at 50% probability. H-atoms and counterions (in 1-OAc and 1-NO2) are omitted, and the 9-BBN substituents and THF ligands in 1-H are displayed in wireframe for improved clarity.
Figure 4.
Figure 4.
Anion competition reaction showing selective nitrite capture by 1 in the presence of fluoride and nitrate (top), selectivity of hydrazine binding to 1 in the presence of 1-mono (middle) and 1H NMR of hydrazine competition experiment (bottom) (N-CH2 and pyz-CH shown). BR2 = 9-BBN and R represents the remainder of the free ligand.
Figure 5.
Figure 5.
μ(1,2)-hydrazine capture using 2–4 to yield 2–4-N2H4 and hydrazine reactivity of 2-N2H4 and 4-N2H4 to generate hydrazido and diazene complexes 5-X and 6 (X = Br, Cl). Molecular structures of 2-N2H4, 3-N2H4, 5-Br and 6 (right). Thermal ellipsoids displayed at 50% probability. Non-diazene or hydrazine H-atoms are omitted, and the 9-BBN substituents are displayed in wireframe for improved clarity.
See this image and copyright information in PMC

References

    1. a) Borovik AS, Acc. Chem. Res 2005, 38, 54–61; - PubMed
    2. b) Spatzal T, Perez KA, Einsle O, Howard JB, Rees DC, Science 2014, 345, 1620–1623; - PMC - PubMed
    3. c) Sippel D, Rohde M, Netzer J, Trncik C, Gies J, Grunau K, Djurdjevic I, Decamps L, Andrade SLA, Einsle O, Science 2018, 359, 1484–1489; - PubMed
    4. d) Van Stappen C, Deng Y, Liu Y, Heidari H, Wang J-X, Zhou Y, Ledray AP, Lu Y, Chem. Rev 2022, 122, 11974–12045; - PMC - PubMed
    5. e) Stripp ST, Duffus BR, Fourmond V, Léger C, Leimkühler S, Hirota S, Hu Y, Jasniewski A, Ogata H, Ribbe MW, Chem. Rev 2022, 122, 11900–11973. - PMC - PubMed
    1. a) Dos Santos PC, Igarashi RY, Lee H-I, Hoffman BM, Seefeldt LC, Dean DR, Acc. Chem. Res 2005, 38, 208–214; - PubMed
    2. b) Zhang X, Houk KN, Acc. Chem. Res 2005, 38, 379–385; - PubMed
    3. c) Prejanò M, Medina FE, Ramos MJ, Russo N, Fernandes PA, Marino T, ACS Catal 2020, 10, 2872–2881; - PMC - PubMed
    4. d) Warshel A, Sharma PK, Kato M, Xiang Y, Liu H, Olsson MHM, Chem. Rev 2006, 106, 3210–3235. - PubMed
    1. Drover MW, Chem. Soc. Rev 2022, 51, 1861–1880. - PubMed
    1. a) Kiernicki JJ, Zeller M, Szymczak NK, J. Am. Chem. Soc 2017, 139, 18194–18197; - PMC - PubMed
    2. b) Kiernicki JJ, Shanahan JP, Zeller M, Szymczak NK, Chem. Sci 2019, 10, 5539–5545. - PMC - PubMed
    1. Miller AJM, Labinger JA, Bercaw JE, J. Am. Chem. Soc 2008, 130, 11874–11875. - PubMed

LinkOut - more resources